# Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal Function

> **NCT00879645** · PHASE1 · TERMINATED · sponsor: **Mallinckrodt** · enrollment: 28 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** Sodium Sulfide
- **DRUG:** Sodium Sulfide
- **DRUG:** Sodium Sulfide
- **DRUG:** Sodium Sulfide

## Key facts

- **NCT ID:** NCT00879645
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** unable to develop a rapid \& reliable assay to detect sulfide concentrations
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879645, "Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00879645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*